---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-005618"
form_type: "8-K"
ticker: "HOWL"
cik: "0001785530"
company_name: "Werewolf Therapeutics, Inc."
filed_at: "2023-01-10T23:59:59+00:00"
generated_at: "2026-06-20T17:12:51.727905+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Werewolf Therapeutics reports 34,275,321 shares outstanding as of Jan 10, 2023

## Summary
- Common shares outstanding: 34,275,321 as of January 10, 2023.
- Trading symbol: HOWL on Nasdaq Global Select Market.
- No financial results or operational updates provided in this filing.

## SEC filing metadata
- accession: 0001193125-23-005618
- form_type: 8-K
- ticker: HOWL
- cik: 0001785530
- company_name: Werewolf Therapeutics, Inc.
- filed_at: 2023-01-10T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1785530/000119312523005618/0001193125-23-005618-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1785530/000119312523005618/d387828d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-005618
- JSON: https://secwatch.observer/filing/0001193125-23-005618.json
- Plain text: https://secwatch.observer/filing/0001193125-23-005618.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.